Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Long-Term Deferred Tax: 2018

  • EyePoint Pharmaceuticals' Long-Term Deferred Tax was N/A to $6.2 million in Q2 2018 from the same period last year, while for Jun 2018 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $6.2 million for FY2018, which is N/A change from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Long-Term Deferred Tax of $6.2 million as of Q2 2018.
  • EyePoint Pharmaceuticals' Long-Term Deferred Tax's 5-year high stood at $6.2 million during Q2 2018, with a 5-year trough of $6.2 million in Q2 2018.
  • Over the past 1 years, EyePoint Pharmaceuticals' median Long-Term Deferred Tax value was $6.2 million (recorded in 2018), while the average stood at $6.2 million.